BNP Paribas Financial Markets’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $38.3M | Buy |
799,604
+12,004
| +2% | +$516K | 0.01% | 891 |
|
|
2026
Q1 | $28.9M | Sell |
787,600
-610,692
| -44% | -$28.9M | 0.01% | 945 |
|
|
2025
Q4 | $71.1M | Buy |
1,398,292
+718,922
| +106% | +$36.8M | 0.03% | 529 |
|
|
2025
Q3 | $37.7M | Buy |
679,370
+89,616
| +15% | +$5.25M | 0.02% | 755 |
|
|
2025
Q2 | $40.7M | Sell |
589,754
-478,162
| -45% | -$32.5M | 0.02% | 675 |
|
|
2025
Q1 | $74.2M | Buy |
1,067,916
+487,392
| +84% | +$40.3M | 0.04% | 446 |
|
|
2024
Q4 | $49.9M | Buy |
580,524
+282,541
| +95% | +$30.6M | 0.03% | 615 |
|
|
2024
Q3 | $35.5M | Buy |
297,983
+208,466
| +233% | +$27.8M | 0.02% | 632 |
|
|
2024
Q2 | $12.8M | Sell |
89,517
-334,410
| -79% | -$44.3M | 0.01% | 971 |
|
|
2024
Q1 | $54.4M | Buy |
423,927
+348,291
| +460% | +$41.5M | 0.05% | 400 |
|
|
2023
Q4 | $7.82M | Buy |
75,636
+40,167
| +113% | +$3.97M | 0.01% | 1156 |
|
|
2023
Q3 | $3.23M | Sell |
35,469
-345,589
| -91% | -$30.4M | ﹤0.01% | 1572 |
|
|
2023
Q2 | $30.8M | Buy |
381,058
+380,266
| +48,013% | +$31.1M | 0.04% | 446 |
|
|
2023
Q1 | $63K | Sell |
792
-56,202
| -99% | -$3.99M | ﹤0.01% | 3402 |
|
|
2022
Q4 | $3.86M | Sell |
56,994
-113,184
| -67% | -$6.64M | 0.01% | 1441 |
|
|
2022
Q3 | $8.48M | Buy |
170,178
+5,766
| +4% | +$309K | 0.01% | 1068 |
|
|
2022
Q2 | $9.16M | Buy |
164,412
+163,772
| +25,589% | +$9.09M | 0.01% | 939 |
|
|
2022
Q1 | $35.5K | Hold |
640
| – | – | ﹤0.01% | 3619 |
|
|
2021
Q4 | $35.8K | Sell |
640
-54
| -8% | -$2.92K | ﹤0.01% | 3796 |
|
|
2021
Q3 | $33.3K | Hold |
694
| – | – | ﹤0.01% | 3594 |
|
|
2021
Q2 | $29.1K | Sell |
694
-404
| -37% | -$15.7K | ﹤0.01% | 3441 |
|
|
2021
Q1 | $37K | Buy |
1,098
+202
| +23% | +$7.2K | ﹤0.01% | 3678 |
|
|
2020
Q4 | $31.3K | Sell |
896
-504
| -36% | -$17.4K | ﹤0.01% | 3739 |
|
|
2020
Q3 | $48.6K | Sell |
1,400
-214
| -13% | -$7.13K | ﹤0.01% | 3478 |
|
|
2020
Q2 | $52.8K | Sell |
1,614
-17,186
| -91% | -$548K | ﹤0.01% | 3009 |
|
|
2020
Q1 | $566K | Buy |
18,800
+15,428
| +458% | +$459K | ﹤0.01% | 2281 |
|
|
2019
Q4 | $97.6K | Buy |
3,372
+1,246
| +59% | +$34.5K | ﹤0.01% | 3303 |
|
|
2019
Q3 | $55K | Sell |
2,126
-108
| -5% | -$2.73K | ﹤0.01% | 3427 |
|
|
2019
Q2 | $57K | Sell |
2,234
-492
| -18% | -$12.2K | ﹤0.01% | 3342 |
|
|
2019
Q1 | $71.3K | Buy |
2,726
+88
| +3% | +$2.16K | ﹤0.01% | 3319 |
|
|
2018
Q4 | $60.8K | Sell |
2,638
-92
| -3% | -$2.04K | ﹤0.01% | 2618 |
|
|
2018
Q3 | $64.3K | Sell |
2,730
-294
| -10% | -$7.17K | ﹤0.01% | 2948 |
|
|
2018
Q2 | $69.7K | Sell |
3,024
-764
| -20% | -$18.2K | ﹤0.01% | 2969 |
|
|
2018
Q1 | $93.3K | Buy |
3,788
+972
| +35% | +$25.5K | ﹤0.01% | 3221 |
|
|
2017
Q4 | $75.6K | Sell |
2,816
-522
| -16% | -$13.3K | ﹤0.01% | 3453 |
|
|
2017
Q3 | $80.4K | Buy |
3,338
+114
| +4% | +$2.58K | ﹤0.01% | 2903 |
|
|
2017
Q2 | $69.1K | Sell |
3,224
-130
| -4% | -$2.62K | ﹤0.01% | 3012 |
|
|
2017
Q1 | $57.5K | Buy |
3,354
+282
| +9% | +$4.91K | ﹤0.01% | 2694 |
|
|
2016
Q4 | $55.1K | Sell |
3,072
-778
| -20% | -$14.1K | ﹤0.01% | 2790 |
|
|
2016
Q3 | $80.1K | Buy |
3,850
+1,656
| +75% | +$41.1K | ﹤0.01% | 2206 |
|
|
2016
Q2 | $59K | Buy |
2,194
+578
| +36% | +$15.9K | ﹤0.01% | 2271 |
|
|
2016
Q1 | $43.8K | Sell |
1,616
-2,296
| -59% | -$61.5K | ﹤0.01% | 2035 |
|
|
2015
Q4 | $114K | Buy |
3,912
+1,748
| +81% | +$48.4K | ﹤0.01% | 2250 |
|
|
2015
Q3 | $58.7K | Sell |
2,164
-188
| -8% | -$5.32K | ﹤0.01% | 2747 |
|
|
2015
Q2 | $64.4K | Buy |
+2,352
| New | +$66.1K | ﹤0.01% | 2332 |
|
|
2013
Q3 | – | Sell |
-17,200
| Closed | -$267K | – | 2665 |
|
|
2013
Q2 | $267K | Buy |
+17,200
| New | +$286K | ﹤0.01% | 2101 |
|
Other funds holding NVO
F
EHC
BNP Paribas Financial Markets's NVO Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its Novo Nordisk (NVO) stake by 1.5% in Q2 2026, buying an estimated $516K and bringing the position to 799,604 shares worth $38.3M. The position accounts for 0.01% of the portfolio, ranked #891.
BNP Paribas Financial Markets first reported a position in NVO in Q2 2013 and has held it in 46 quarters since. The position peaked at $74.2M in Q1 2025. 1,157 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- BNP Paribas Financial Markets held 799,604 shares of Novo Nordisk worth $38.3M as of Q2 2026.
- BNP Paribas Financial Markets bought 12,004 Novo Nordisk shares in Q2 2026, an estimated $516K.
- Novo Nordisk made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #891 holding.
- BNP Paribas Financial Markets first reported a position in Novo Nordisk in Q2 2013 and has held it in 46 quarters since.
- BNP Paribas Financial Markets's Novo Nordisk position peaked at $74.2M in Q1 2025.
- 1,157 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.